The Clearing Price Knows More Than the Mark: UK Private Equity Secondaries in 2026

The UK private equity secondary market has become a standing item on the institutional calendar. Pension schemes, insurers, wealth managers and family offices now treat the secondary route as a normal portfolio tool rather than an emergency exit. Yet the language used to describe it remains imprecise. Transactions are routinely summarised as clearing at a discount to net asset value, as though NAV were a price and the discount were a single, comparable number. Neither is quite true.

A discount to what, exactly?

NAV is an estimate. It is prepared by the general partner, usually under the International Private Equity and Venture Capital Valuation Guidelines, audited annually and updated quarterly. It is not a traded price, and it is not a settlement value. In a market where listed comparables have re-rated and mid-market transaction multiples have narrowed, the interval between the last valuation letter and the next liquidity event matters a great deal.

A secondary buyer is not purchasing the last reported NAV. The buyer is purchasing a future cash-flow stream, with all the uncertainty that entails: the timing of exits, the cost of unfunded commitments, the tail of the fund and the GP's ability to realise assets in a thin market. The discount is therefore a composite price for time, uncertainty and selection. Treating it as a verdict on the asset class is a category error.

Three discounts, not one

For UK limited partners, it helps to decompose the headline discount into three components.

The first is a liquidity discount — the genuine cost of asking for cash before the fund would otherwise return it. This is the cleanest part of the discount and the easiest to justify. A seller with a fixed timetable pays for certainty.

The second is a recognition discount — the gap between the reported mark and the price a buyer would pay for the same assets today. This is not necessarily evidence of distress. It is evidence of a valuation convention that prioritises consistency over immediacy. A fund marked at 1.0x last quarter may be fairly marked, but it is not marked to a transaction.

The third is a selection discount — the premium buyers demand because the assets on offer are not a random sample. Sellers choose what to sell. Buyers know this, and they price it. A portfolio offered at a headline discount may contain a concentration of slower-moving assets, or a tail of companies whose exit routes are less obvious than the headline multiple suggests.

A 12 per cent discount on a fund with a 5 per cent carry accrual and a 9 per cent mark lag is not the same as a 12 per cent discount on a fund marked conservatively. The arithmetic is identical; the economics are not.

The denominator is still doing the work

The supply of secondary assets in 2026 is not primarily a story of forced selling. It is a story of portfolio arithmetic. UK defined benefit schemes in surplus are reviewing their growth allocations. Local government pension schemes are consolidating assets through pooling arrangements, which creates both scale and a rationale for pruning manager relationships. Defined contribution default funds and wealth platforms are managing liquidity against regular redemptions. None of these sellers is distressed in the traditional sense, but many are time-constrained.

At the same time, the distribution drought of recent years has left LPs with less cash coming back than they underwrote. The exit queue — the backlog of portfolio companies awaiting a sale or listing — is clearing slowly. London's IPO window remains selective, trade buyers are disciplined, and continuation vehicles absorb some but not all of the pressure. The result is a market where the secondary route is often the most reliable form of liquidity available, and where the price reflects that reliability.

The GP-led question

A growing share of UK secondary activity is GP-led, whether through continuation vehicles, preferred equity or structured strips. These transactions can be efficient, but they place the GP on both sides of the table. The conflict is manageable, not eliminable. Limited partner advisory committees are now expected to scrutinise the fairness opinion, the status quo alternative and the terms of any stapled primary commitment.

The discount in a GP-led deal is often narrower than in a traditional LP-led sale, because the GP has an incentive to anchor the price and because the buyer is often buying a concentrated, better-understood pool. But a narrower discount is not automatically a better outcome. The terms may embed a cost — through carry reset, fee structures or deferred consideration — that does not appear in the headline percentage. UK LPs should read the economics in full, not just the mark.

What a UK LP should underwrite

Before treating a secondary discount as either a bargain or a warning, limited partners should ask a short set of questions.

• What is the unfunded commitment profile? A fund with substantial dry powder is not the same as a fund nearing the end of its investment period. The buyer inherits the obligation to fund, and that obligation is priced.
• What is the vintage and the tail? Older funds with a small number of remaining assets carry more execution risk per pound of NAV than diversified pools.
• How was the mark constructed? Valuation frequency, comparable selection and the GP's willingness to mark down matter more than the headline multiple.
• What is the carry position? A fund deep into its carry accrual has a different sensitivity to a small change in exit values than one below its hurdle.
• Who is the buyer, and how is the buyer financed? Leverage in the secondary buyer's structure can shorten the buyer's time horizon and affect the price offered.
• What does the look-through say? Underlying earnings multiples, growth rates and leverage at the portfolio company level are more informative than a fund-level discount.

A price for uncertainty, not a verdict

The secondary market is a price discovery mechanism. In 2026, it is telling UK LPs something useful: liquidity has a cost, marks have a lag, and buyers are discriminating. That is not a reason to avoid the market. It is a reason to read the discount properly.

For sellers, the discipline is to compare the clearing price with a realistic assessment of the fund's cash-flow profile, not with the last NAV letter. For buyers, the opportunity lies in distinguishing between a mark that is stale and an asset that is impaired. For GPs, the priority is transparency: a valuation policy that anticipates the secondary question is more credible than one that defends the last round.

The discount is a question, not an answer. The LPs who treat it as a single number will overpay for certainty. Those who decompose it will find a market that is neither as cheap nor as costly as the headline suggests — and, occasionally, a mark that has not yet caught up with reality.